Table 3.
HPV genotype prevalence determined with each type of specimen.
| HPV genotype | Self-collected specimens, n = 244 | Provider-collected specimens, n = 230 | ||||||
|---|---|---|---|---|---|---|---|---|
| Total infections | Multiple infection | Prevalence | 95% CI∗ | Total infections | Multiple infection | Prevalence | 95% CI∗ | |
| HPV16b, q, n | 15 | 9 | 5.9 | 3.0–9.0 | 6 | 1 | 2.4 | 1.0–5.0 |
| HPV35 | 12 | 9 | 4.7 | 2.0–8.0 | 7 | 2 | 2.8 | 1.0–5.0 |
| HPV40 | 12 | 9 | 4.7 | 2.0–8.0 | 4 | 4 | 1.6 | 0.0–4.0 |
| HPV45n | 11 | 7 | 4.3 | 2.0–7.0 | 5 | 2 | 2.0 | 0.0–4.0 |
| HPV58n | 10 | 5 | 4.0 | 2.0–7.0 | 7 | 1 | 2.8 | 1.0–5.0 |
| HPV18b, q, n | 9 | 7 | 3.6 | 1.0–6.0 | 6 | 1 | 2.4 | 1.0–5.0 |
| HPV66 | 8 | 5 | 3.2 | 1.0–6.0 | 6 | 6 | 2.4 | 1.0–5.0 |
| HPV59 | 7 | 5 | 2.8 | 1.0–5.0 | 3 | 2 | 1.2 | 0.0–3.0 |
| HPV6q, n | 7 | 4 | 2.8 | 1.0–5.0 | 3 | 0 | 1.2 | 0.0–3.0 |
| HPV31n | 7 | 2 | 2.8 | 1.0–5.0 | 2 | 0 | 0.8 | 0.0–2.0 |
| HPV74 | 7 | 2 | 2.8 | 1.0–5.0 | 1 | 0 | 0.4 | 0.0–1.0 |
| HPV42 | 5 | 3 | 2.0 | 0.0–4.0 | 5 | 4 | 2.0 | 0.0–4.0 |
| HPV52n | 5 | 3 | 2.0 | 0.0–4.0 | 4 | 2 | 1.6 | 0.0–4.0 |
| HPV51 | 5 | 4 | 2.0 | 0.0–4.0 | 3 | 3 | 1.2 | 0.0–3.0 |
| HPV62 | 5 | 3 | 2.0 | 0.0–4.0 | 2 | 1 | 0.8 | 0.0–2.0 |
| HPV81 | 5 | 3 | 2.0 | 0.0–4.0 | 1 | 1 | 0.4 | 0.0–1.0 |
| HPV83 | 5 | 4 | 2.0 | 0.0–4.0 | 1 | 0 | 0.4 | 0.0–1.0 |
| HPV72 | 5 | 5 | 2.0 | 0.0–4.0 | ND | ND | ND | |
| HPV90 | 5 | 4 | 2.0 | 0.0–4.0 | ND | ND | ND | |
| HPV67 | 4 | 2 | 1.6 | 0.0–3.0 | 1 | 1 | 0.4 | 0.0–1.0 |
| HPV53 | 4 | 2 | 1.6 | 0.0–3.0 | ND | ND | ND | |
| HPV56 | 3 | 3 | 1.2 | 0.0–3.0 | 1 | 0 | 0.4 | 0.0–1.0 |
| HPV33n | 3 | 3 | 1.2 | 0.0–3.0 | ND | ND | ND | |
| HPV70 | 3 | 3 | 1.2 | 0.0–3.0 | ND | ND | ND | |
| HPV87 | 2 | 2 | 0.8 | 0.0–2.0 | 2 | 1 | 0.8 | 0.0–2.0 |
| HPV39 | 2 | 2 | 0.8 | 0.0–2.0 | 1 | 0 | 0.4 | 0.0–1.0 |
| HPV30 | 2 | 1 | 0.8 | 0.0–2.0 | 1 | 1 | 0.4 | 0.0–1.0 |
| HPV54 | 2 | 2 | 0.8 | 0.0–2.0 | 1 | 0 | 0.4 | 0.0–1.0 |
| HPV44 | 2 | 1 | 0.8 | 0.0–2.0 | ND | ND | ND | |
| HPV86 | 2 | 0 | 0.8 | 0.0–2.0 | ND | ND | ND | |
| HPV82 | 1 | 0 | 0.4 | 0.0–1.0 | 1 | 0 | 0.4 | 0.0–1.0 |
| HPV84 | 1 | 1 | 0.4 | 0.0–1.0 | 1 | 0 | 0.4 | 0.0–1.0 |
| HPV68 | 1 | 1 | 0.4 | 0.0–1.0 | ND | ND | ND | |
| HPV69 | 1 | 1 | 0.4 | 0.0–1.0 | ND | ND | ND | |
| HPV85 | 1 | 1 | 0.4 | 0.0–1.0 | ND | ND | ND | |
| HPV91 | 1 | 0 | 0.4 | 0.0–1.0 | ND | ND | ND | |
| HPV73 | 1 | 0 | 0.4 | 0.0–1.0 | ND | ND | ND | |
| HPV43 | ND | ND | ND | 1 | 0 | 0.4 | 0.0–1.0 | |
ND = not detected ∗Differences in the prevalences were not significant since each pair of 95% CI overlapped. bBivalent HPV type, qquadrivalent HPV type, nnonavalent HPV type.